Hengrui Pharma

Hengrui Pharma is a leading global pharmaceutical company committed to the research, development, and commercialization of high-quality medicines. Focusing on addressing unmet clinical needs, Hengrui Pharma operates with a strong dedication to advancing human health. With a global R&D team comprising over 5,500 professionals across 14 R&D centers, Hengrui Pharma is at the forefront of therapeutic innovation.

Hengrui Pharma's primary address is located in Pudong New Area, Shanghai, China, at No. 1288, Haike Road, Shanghai. The company's core therapeutic areas include oncology, metabolic and cardiovascular diseases, immunological and respiratory diseases, and neuroscience. Hengrui has successfully commercialized 19 new molecular entity drugs and 4 other innovative drugs in China, demonstrating its commitment to scientific and technological advancements in healthcare.

Driven by the principle of putting patients first, Hengrui Pharma continues to strive to conquer diseases, improve health, and extend lives through innovative pharmaceutical solutions. Information about Hengrui Pharma is being continuously updated with the support of the company’s management. We invite the managers of Hengrui Pharma to create a customized and exclusive company showcase and product listing on our platform to further enhance their global presence.